C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2002
10/24/2002	CA2444455A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
10/24/2002	CA2443870A1 Cyclohexylphenyl vasopressin agonists
10/24/2002	CA2443805A1 Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
10/24/2002	CA2443734A1 Method of inhibiting adhesion formation
10/24/2002	CA2443568A1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002	CA2443567A1 Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereofas tocolytic oxytocin receptor antagonists
10/24/2002	CA2431553A1 Cxcr3 antagonists
10/23/2002	EP1251125A2 New camptothecin analogues, preparation methods thereof, use thereof as drugs, and pharmaceutical compositions containing them
10/23/2002	EP1250340A1 Methods and compounds for inhibiting mrp1
10/23/2002	EP1250337A1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/23/2002	EP1250335A2 Process and intermediates for the preparation of imidazopyridines
10/23/2002	EP1250334A2 Agents and methods for the treatment of proliferative diseases
10/23/2002	EP1250328A1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
10/23/2002	EP1250326A2 Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation
10/23/2002	EP1196384A4 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
10/23/2002	EP1091959B1 Novel pyrrolo-(3,4-b)quinoline derivatives, method for the production and use thereof as a medicament
10/23/2002	CN1093130C Substituted pyrido 6,6-bicyclic derivatives
10/23/2002	CN1093123C Aralkyl and aralkylidene heterocyclic lactams and imides
10/22/2002	US6469171 Syntheses of a variety of lamellarin compounds and analogues
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469039 Benzimidazoles; thrombin- inhibiting activity and the effect of extending thrombin time
10/22/2002	US6469031 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
10/22/2002	US6469024 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
10/22/2002	US6469021 Non-peptide antagonists of GLP-1 receptor and methods of use
10/22/2002	US6469020 Hydroxamic and carboxylic acid derivatives
10/22/2002	US6469003 Pyridazinone derivatives
10/22/2002	US6468998 Pyrrolidine compounds and medicinal utilization thereof
10/22/2002	US6468996 Substituted hetero-polycyclic compounds as PPARα and PPARγ activators
10/22/2002	CA2253914C Camptothecin-skeleton compounds isolated from mappia foetida and the use thereof as syntones for novel medicaments as well as therapeutical agents
10/22/2002	CA2227264C Amine acid salt compounds and process for the production thereof
10/17/2002	WO2002081475A1 Jun kinase inhibitors
10/17/2002	WO2002081474A1 Triazolophthalazine / quinoline / isoquinoline derivatives which are ligands for gaba-a receptors containing the alpha 5 subtype
10/17/2002	WO2002081471A1 Beta-carboline derivatives and its pharmaceutical use against depression and anxiety
10/17/2002	WO2002081448A1 Benzamidine derivative
10/17/2002	WO2002081447A1 3-cyclopentyloxy-4-methoxyphenyl-isothiazolinone derivatives and the use thereof
10/17/2002	WO2002081446A1 3-cyclopentyloxy-4-methoxyphenyl-isoindolinone derivatives and the use thereof
10/17/2002	WO2002080957A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease
10/17/2002	WO2002080928A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002	WO2002080914A2 Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments
10/17/2002	WO2002080911A2 Use of substituted imidazo[1,2-a]-pyridine-3-yl-amide and imidazo[1,2-a]-pyridine-3-yl-amine compounds as medicaments for the treatment of neurodegenerative diseases
10/17/2002	WO2002066477A3 Imidazopyridines
10/17/2002	WO2002044156A3 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
10/17/2002	WO2002019213A3 Method for treatment of migraine using pde5 inhibitors
10/17/2002	WO2001053298A9 Imidazopyridines and related azacyclic derivatives as selective modulators of bradykinin b2 receptors
10/17/2002	US20020151713 Substituted 6,5-hetero-bicyclic derivatives
10/17/2002	US20020151574 Extracellular signal regulated kinase (ERK); anticancer agents and protein kinase inhibitors
10/17/2002	US20020151557 CRF receptor antagonists and methods relating thereto
10/17/2002	US20020151550 Such as (2-chloro-3,4-dimethoxyphenyl)-N-((1-((2-methoxy phenyl)methyl)benzimidazol-2-yl)methyl)-N-(3-methylbutyl) carboxamide; useful in the diagnosis and treatment of renal diseases, heart failure, hypertension
10/17/2002	US20020151549 Such as 3-(6-bromo-2-methylimidazo(1,2-a)pyridin-3-yl)-1H-pyrazol-1-yl 2-methyl-5-nitrophenyl sulfone; useful as phosphatidylinositol-3-kinase (PI3K) inhibitors and antitumor agents
10/17/2002	US20020151544 Phosphatidylinositol 3-kinase (PI3K) inhibitors/anticancer agents such as N-(2-(3-benzenesulfonylaminophenyl)-4-morphoniloquinazolin-6-yl)acetamide
10/17/2002	US20020151538 Azepin-2-one derivatives useful for treating Alzheimer's disease
10/17/2002	US20020150535 Methods for diagnosing and monitoring treatment ADHD by assessing the dopamine transporter level
10/17/2002	US20020149000 3.3.1-diazabicyclo structures bearing a heteroatom on the nitrogens
10/17/2002	DE10117184A1 Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen Substituted imidazol [1,2-a] pyridin-3-yl-amide, and amine compounds of
10/17/2002	CA2443108A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002	CA2442996A1 Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments
10/17/2002	CA2442986A1 Use of substituted imidazo[1,2-a]-pyridine-3-yl-amide and imidazo[1,2-a]-pyridine-3-yl-amine compounds as medicaments
10/17/2002	CA2442904A1 Benzamidine derivative
10/17/2002	CA2440196A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease
10/16/2002	EP1249451A2 Bicyclic-substituted 4-amino-pyridopyrimidine derivatives
10/16/2002	EP1248790A1 Proton pump inhibitors
10/16/2002	EP1248784A1 Condensed azepines as vasopressin agonists
10/16/2002	EP1248770A1 1,3,4-substituted piperidine analogs and uses thereof in treating addictions
10/16/2002	EP1248621A1 Method and composition for the treatment of pain
10/16/2002	EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002	EP0975632B1 Alkaloid halide salts of swainsonine and methods of use
10/16/2002	EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002	EP0542136B1 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl) piperidines, piperazines and pyrrolidines as antipsychotic agents
10/16/2002	CN1375059A Fluorescent compounds for use in industrial water systems
10/16/2002	CN1374967A Compounds for the treatment of ischemia
10/16/2002	CN1374960A Novel integrain receptor antagonists
10/16/2002	CN1374953A Aromatic nitrogenous six-membered ring compounds
10/16/2002	CN1374952A Benzimidazolone derivatives and their use as phosphodiesterase inhibibors
10/16/2002	CN1374950A Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/16/2002	CN1374865A Nociceptin receptor ORL-1 agonists for use in treating cough
10/15/2002	USRE37886 4-(1-(3,5bis(trifluoromethyl) benzoyl)-2-(phenylmethyl)-4-piperidinyl)-n-(2,6dimethylphenyl)-1-piperazine acetamide, having tachykinin and substance p antagonistic activity; analgesic and antiinflammatory agents
10/15/2002	US6465654 Antiviral agents, that induce biosynthesis of interferon, and inhibit tumor formation
10/15/2002	US6465511 Treatment of septic shock
10/15/2002	US6465507 Antitumor agents
10/15/2002	US6465491 6-phenylpyridyl-2-amine derivatives
10/15/2002	US6465485 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
10/15/2002	US6465484 Tyrosine kinase inhibitors; cancer, atherosclerosis, diabetic retinopathy, autoimmune diseases, inflammatory diseases
10/15/2002	US6465482 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
10/15/2002	US6465481 Exhibit electrophysiological activity; may be more potent and produce fewer side effects including lower incidence of proarrhythmias such as torsades de pointes
10/15/2002	US6465478 Analgesics, antiinflammatories, diuretics, anesthetics, neuroprotective agents, antihypertensive or antianxiety agent, appetite control, hearing regulation
10/15/2002	US6465465 Phosphodiesterase inhibitors
10/15/2002	US6465450 Vanadium (IV) complexes containing catecholate ligand and having spermicidal activity
10/15/2002	US6465449 Heteroaromatic bicyclic derivatives useful as anticancer agents
10/15/2002	US6465433 Boronic ester and acid compounds, synthesis and uses
10/15/2002	CA2066943C Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments
10/10/2002	WO2002080163A1 Optical data carrier containing a cyclizable compound in the information layer
10/10/2002	WO2002080160A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
10/10/2002	WO2002079201A1 Europium compounds and ink compositions containing the same
10/10/2002	WO2002079198A1 Pyridazinone aldose reductase inhibitors
10/10/2002	WO2002079191A1 Viologen linked acridine based molecule and process for the preparation thereof
10/10/2002	WO2002079189A2 Spiroisoquinoline compounds, methods for their preparation and intermediates
10/10/2002	WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002	WO2002078705A1 Hsp inductor
10/10/2002	WO2002078701A1 Use of pyrazolopyridines as therapeutic compounds
10/10/2002	WO2002078700A1 Pyralopyridines, process for their preparation and use as therapteutic compounds

1 ... 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 ... 646